HFA/HFSA/JHFS Position Statement on Endomyocardial Biopsy.

May 24, 2021

Contributor: Petar M Seferović,Hiroyuki Tsutsui,Dennis M McNamara,Arsen D Ristić,Cristina Basso,Biykem Bozkurt,Leslie T Cooper,Gerasimos Filippatos,Tomomi Ide,Takayuki Inomata,Karin Klingel,Aleš Linhart,Alexander R Lyon,Mandeep R Mehra,Marija Polovina,Ivan Milinković,Kazufumi Nakamura,Stefan D Anker,Ivana Veljić,Tomohito Ohtani,Takahiro Okumura,Thomas Thum,Carsten Tschöpe,Giuseppe Rosano,Andrew J S Coats,Randall C Starling

HFA/HFSA/JHFS Position Statement on Endomyocardial Biopsy.

Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the monitoring of heart transplant (HTx) rejection. In addition, EMB can have an important complementary role to the clinical assessment in establishing the diagnosis of diverse cardiac disorders, including myocarditis, cardiomyopathies, drug-related cardiotoxicity, amyloidosis, other infiltrative and storage disorders, and cardiac tumours. Improvements in EMB equipment and the development of new techniques for the analysis of EMB samples has significantly improved diagnostic precision of EMB. The present document is the result of the Trilateral Cooperation Project between the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America, and the Japanese Heart Failure Society. It represents an expert consensus aiming to provide a comprehensive, up-to-date perspective on EMB, with a focus on the following main issues: 1) an overview of the practical approach to EMB, 2) an update on indications for EMB, 3) a revised plan for HTx rejection surveillance, 4) the impact of multimodality imaging on EMB, and 5) the current clinical practice in the worldwide use of EMB.
Copyright © 2021. Published by Elsevier Inc.

Author

admin

View all posts

About The Expert

Petar M Seferović

Serbian Academy of Sciences and Arts, Belgrade, Serbia. Electronic address: seferovic.petar@gmail.com.

Hiroyuki Tsutsui

Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.

Dennis M McNamara

Heart and Vascur Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Arsen D Ristić

Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Cristina Basso

Cardiovascular Pathology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.

Biykem Bozkurt

Winters Center for Heart Failure, Cardiovascular Research Institute, Baylor College of Medicine, Michael E.DeBakey VA Medical Center, Houston, TX, USA.

Leslie T Cooper

Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, USA.

Gerasimos Filippatos

Attikon University Hospital, Department of Cardiology, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

Tomomi Ide

Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.

Takayuki Inomata

Department of Cardiovascular Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.

Karin Klingel

Cardiopathology, Institute for Pathology, University Hospital, Tuebingen, Germany.

Aleš Linhart

Department of Cardiovascular Medicine, Charles University, Prague, Czech Republic.

Alexander R Lyon

National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK.

Mandeep R Mehra

Heart and Vascular Center, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA.

Marija Polovina

Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Ivan Milinković

Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Kazufumi Nakamura

Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Stefan D Anker

Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin, Germany.

Ivana Veljić

Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.

Tomohito Ohtani

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Takahiro Okumura

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Thomas Thum

Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.

Carsten Tschöpe

Berlin Institute of Health (BIH) and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Department of Cardiology, Campus Virchow Klinikum, Charite University, Berlin, Germany.

Giuseppe Rosano

Department of Medical Sciences, IRCCS San Raffaele, Rome, Italy, and Cardiology Clinical Academic Group, St George’s Hospitals NHS Trust.

Andrew J S Coats

Monash University, Australia, and University of Warwick, Coventry, UK.

Randall C Starling

Cleveland Clinic, Cleveland OH, USA.

References

PubMed